The half-life comes from the FDA label: "The elimination half-life is approximately 5-6 days."1 Everything else on this page follows from that number and from the fact that weekly doses overlap. The calculator turns it into dates for your own last injection, for Zepbound and Mounjaro, which are the same drug, and for Wegovy and Ozempic, which last longer.
The sections after it cover the questions people usually have in mind when they ask this: how the body gets rid of the drug and whether anything speeds that up, whether a higher dose stays longer, how long the effects last, and what the timing means for surgery, pregnancy or switching to another medicine.
How much is left in my body today?
Enter the date of your last injection, and say what came before it: weekly doses for a month or more, or a single first dose. The chart shows the modelled level as a share of your usual weekly peak, and the list gives the date of each milestone.
With your doses logged, the app shows this level for any day without entering anything.
Open the app100% is the weekly peak on a steady schedule, whatever your dose. The numbers along the bottom are days after the last injection. A model of an average body built on the label's half-life; it is not a blood test.
The curve has two parts. For the first day or two after an injection the level is still rising, because the dose is absorbed slowly from under the skin; the label gives 24 hours as the typical time to the peak, and anything from 8 to 72 hours as possible.1 After that it falls by the same fraction every day. That steady fraction is what "half-life" describes.
What does a half-life of 5 to 6 days mean?
It means that after every 5 to 6 days, half of what was in the body is gone. The second half-life removes half of the remainder, and so on. The amount never reaches zero on paper, but it becomes negligible quickly.
| Half-lives passed | Days, at 5 to 6 days each | Still in the body | Gone |
|---|---|---|---|
| 1 | 5 to 6 | 50% | 50% |
| 2 | 10 to 12 | 25% | 75% |
| 3 | 15 to 18 | 12.5% | 87.5% |
| 4 | 20 to 24 | 6.3% | 93.7% |
| 5 | 25 to 30 | 3.1% | 96.9% |
| 6 | 30 to 36 | 1.6% | 98.4% |
| 7 | 35 to 42 | 0.8% | 99.2% |
Pharmacologists usually call a drug cleared after about five half-lives, when around 3% is left. For Zepbound that is 25 to 30 days. This is where the common answer "about a month" comes from. The label of Wegovy applies the same reasoning to its own drug and prints the result: with a half-life of about a week, semaglutide "will be present in the circulation for about 5 to 7 weeks after the last" dose.2
The Zepbound label uses the half-life in one practical instruction. In its section on overdose it says a period of observation may be needed, "taking into account the half-life of tirzepatide of approximately 5 days".1 A dose that turns out to be too much cannot be taken back, and it fades on the schedule in the table.
Why do sources say 25 days, 30 days and 5 weeks?
Because they are all multiplying the same half-life, and choosing different stopping points. Three choices explain nearly every figure you will see quoted.
- Which half-life. The label says "approximately 5-6 days" in its pharmacology section and "approximately 5 days" in the overdose section. Five half-lives are 25 days with one and 30 days with the other.
- How many half-lives. Five leaves about 3%. Seven leaves under 1% and gives 35 to 42 days, which is where "5 to 6 weeks" comes from.
- Where the count starts. The level peaks a day or more after the injection, so counting from the injection adds a day or two to counting from the peak.
None of these answers is wrong. "About a month" is a fair summary of all of them, and the calculator shows the exact day for whichever threshold you care about.
What happens week by week after the last injection?
The table lines the falling level up with the rules in the labels, since several of those rules are tied to how much drug is left.
| Day | Level left | What it corresponds to |
|---|---|---|
| 1 to 2 | 100% | The weekly peak |
| 7 | 44% | The usual low point; the next dose would be due |
| 11 | 26% | The 4-day window for a late dose closes |
| 14 | 17% | One dose missed |
| 18 | 10% | A tenth of the peak |
| 21 | 6% | Two doses missed |
| 27 | 3% | Five half-lives; the usual meaning of "cleared" |
| 35 | under 1% | Seven half-lives |
Zepbound or Mounjaro after at least a month of weekly doses. From the model; days counted from the last injection.
Day 11 is the last day on which the label allows a missed Zepbound dose to be taken: "within 4 days (96 hours) after the missed dose".1 By then the level is down to about a quarter of the peak. Beyond day 14 the Zepbound label has no instruction for restarting. The Wegovy label does have one for its own drug: after two or more missed doses, the dose escalation is started again from a lower dose.2 The table shows what that provision is reacting to. Three weeks after the last injection, a person is close to where they were before the first one.
Why does it last longer after months of use than after one dose?
Because weekly doses stack. A week after an injection about 44% of its peak is still there when the next one arrives. The second dose lands on top of that remainder, the third on top of both, and the level climbs for about four weeks until what is added each week equals what is lost. The label states that this steady state is reached "following 4 weeks of once weekly administration".1
In the model, a single first dose peaks at about 61% of the level that the same dose settles at after a month. So a person who stops after one injection starts the countdown from a lower point than a person who stops after a year. The half-life is identical in both cases. What differs is the height the level falls from: after one dose it is under 3% of the settled peak on about day 23, and after long use on about day 27.
The length of treatment beyond the first month makes no further difference. Six months and three years of weekly doses leave the same amount in the body, because the level stopped rising after week 4. A drug with this half-life does not keep building up.
Does a higher dose stay in the body longer?
It takes the same time to halve, and a longer time to fall to any fixed amount. The label says exposure to tirzepatide "increases in a dose-proportional manner": 15 mg puts six times as much drug in the body as 2.5 mg.1 Six times as much needs about two and a half extra half-lives to come down to the same point.
Days after the last injection, for someone who had been on the dose for at least a month. Compared with the usual weekly peak on each lower dose.
A person who stops from 15 mg has, two weeks later, about as much drug in the body as a person on 2.5 mg has at their weekly peak. From 10 mg that point comes after about 11 days, and from 5 mg after about 6. This matters for anyone who restarts after a break, because the body is no longer used to the dose it left. Our missed dose page covers what the labels say about restarting.
How does the body get rid of Zepbound?
It takes the drug apart. Tirzepatide is a small protein, a chain of amino acids with a fatty side chain attached, and the body handles it the way it handles its own proteins. The label lists three processes: "proteolytic cleavage of the peptide backbone, beta-oxidation of the C20 fatty diacid, and amide hydrolysis".1 In plain terms, enzymes cut the chain into pieces and burn the fatty part.
The pieces leave in urine and stool. The drug itself does not: "Intact tirzepatide is not observed in urine or feces." That detail explains most of what follows, because a drug that is dismantled all over the body does not depend on one organ to remove it.
The slow pace is deliberate. The fatty side chain makes the molecule cling to albumin, the main protein in blood. The label says tirzepatide is 99% bound to it and that this binding "prolongs the half-life". While it is attached to albumin the drug is shielded from the enzymes that would break it down, and that is what turns an injection into a once-a-week treatment.
Does it last longer in some people?
A little, and not for the reasons people expect. The label gives the typical clearance as about 0.06 litres per hour, with a variation between people of roughly 20%.1 One person's half-life may be nearer 5 days and another's nearer 6. That is the range printed on the label, and it moves the dates in the calculator by a few days in either direction.
The usual suspects make no meaningful difference. According to the label, age from 18 to 84, sex, race, ethnicity and body weight "do not have a clinically relevant effect" on how the body handles tirzepatide. Kidney disease does not either: "Renal impairment does not impact the pharmacokinetics of tirzepatide", and that held even in people with end-stage kidney disease. The same is stated for liver disease.1 No dose adjustment is recommended for any of these groups.
Older adults were part of the evidence. In the two main trials 226 people on Zepbound, 9% of the total, were 65 or older, and the label reports that safety and effectiveness in this group did not differ from those in younger adults. Its pharmacology section covers ages up to 84. For the sleep apnea trials it adds that too few people over 65 took part to say the same.1
The label also never asks for the drug level to be measured. No dose is chosen from a blood level and no test of it is part of treatment, which is why a model built on the half-life is the practical way to estimate what is left.
Changes how long it stays?
Can I flush it out faster?
Nothing in the label suggests you can. Tirzepatide is not filtered out whole by the kidneys. It is bound to albumin and broken down by enzymes at a rate set by its structure, and drinking water, exercising or sweating does not change that rate. The label describes no antidote and no way to remove it, and its only instruction for an overdose is supportive care and time.1
Drinking enough is still worth doing after a dose that disagrees with you, for a different reason: vomiting and diarrhea cause dehydration, and the label warns that dehydration can harm the kidneys. Fluids treat the consequence. They do not shorten the drug's stay.
How long do the effects last after the last dose?
The trials measured this in months, and the calculator above is the only guide to the first weeks. No published trial recorded appetite or side effects day by day after stopping. What exists is the drug level, which falls by half about every week, and one large trial of what happens to weight.
In SURMOUNT-4, 670 people who had taken tirzepatide for 36 weeks were assigned to continue or to switch to placebo without knowing which. Over the following year the placebo group regained 14.0% of their body weight, while the group that continued lost a further 5.5%.3 The effect on weight does not outlast the drug by long.
A second trial followed people for longer on a lower dose or none. In SURMOUNT-MAINTAIN, adults who had lost weight on 10 or 15 mg were assigned to stay on that dose, drop to 5 mg or switch to placebo. A year later the average loss from the starting weight was 21.9% for those who stayed, 16.6% on 5 mg and 9.9% on placebo.7 More than half of the loss was gone a year after the drug was. For semaglutide the picture is similar: in the extension of its main trial, 327 people who had lost 17.3% of their weight over 68 weeks regained 11.6 percentage points in the year after stopping, leaving a net loss of 5.6%.6
Put next to the calculator, these trials say something simple. The drug is out of the body in about a month. Its effect on weight unwinds over the following year. The two timescales are different because body weight changes slowly whatever the cause.
For side effects the reasoning runs the other way, and it is reassuring. Stomach and bowel side effects depend on the drug being present. As the level falls to a quarter in about 11 days and to a tenth in about 18, there is progressively less to cause them. If you have stopped because of a side effect and it is not easing over that time, that is worth reporting, because it may not be the drug.
How long does it take to build up in the first place?
The same half-life works in reverse at the start. The first injection peaks about a day later, at roughly 61% of the level it will eventually settle at. Each weekly dose adds to what is left of the previous ones: about 85% after the second, 94% after the third and 98% after the fourth. That is why the label keeps everyone on each dose for at least 4 weeks before the next increase.1
So it takes about four weeks to arrive and about four weeks to leave. Our page on the first week and first month follows the build-up by date, and the dosing schedule shows it across every dose step.
When in the week is the level highest and lowest?
Highest about a day after the injection, lowest just before the next one. On a steady schedule the model puts the low point at about 44% of the peak for Zepbound and 62% for Wegovy. The injection day sets the rhythm of the whole week: a Sunday injection means a Monday or Tuesday peak and a Saturday or Sunday low.
If your appetite differs between the start and the end of the week, this rhythm is the likely reason. Our page on why the day before your shot feels different looks at that swing. It is the same half-life seen on a smaller scale: the level never gets the chance to fall further than one week allows.
The place you inject does not move the curve. The label reports that about 80% of an injected dose reaches the bloodstream and that "similar exposure was achieved" from the abdomen, the thigh and the upper arm.1 Changing sites changes neither how much arrives nor how long it stays.
How do Wegovy and Ozempic compare?
They stay about 40% longer. Wegovy and Ozempic are both semaglutide, and the Wegovy label gives its half-life as "approximately 1 week".2 Mounjaro is tirzepatide, the same drug as Zepbound, so its numbers are the same.4
| Days after the last injection | Zepbound, Mounjaro | Wegovy, Ozempic |
|---|---|---|
| 7 | 44% | 62% |
| 14 | 17% | 31% |
| 21 | 6% | 16% |
| 28 | 2% | 8% |
| 35 | under 1% | 4% |
| 42 | under 1% | 2% |
| 49 | under 1% | 1% |
Share of the usual weekly peak after a steady run of weekly doses, from the model. The Wegovy column agrees with that label's own statement of 5 to 7 weeks in the circulation.
The difference shows up in the labels' rules. Zepbound allows a missed dose to be taken up to 4 days late, Wegovy up to 5. And only the Wegovy label sets a waiting time before pregnancy, as the next section describes. A simulation published in 2026 by researchers at Novo Nordisk, which makes semaglutide, put numbers on the same contrast: after a single missed weekly dose the exposure to tirzepatide fell by half or more, and for semaglutide that took a full seven extra days.5
The rest of the class
The same arithmetic applies to every drug of this kind, and the half-lives differ widely. The 2026 comparison lists them side by side.5
| Drug | How it is taken | Half-life | Five half-lives days |
|---|---|---|---|
| Semaglutide (Wegovy, Ozempic) | Weekly injection or daily tablet | 7 days | 35 |
| Tirzepatide (Zepbound, Mounjaro) | Weekly injection | 5 days | 25 |
| Orforglipron | Daily tablet | 1 to 2 days | 5 to 10 |
| Liraglutide (Saxenda) | Daily injection | about half a day | 2 to 3 |
A drug taken daily has to have a short half-life, and a short half-life means it is gone within days of the last dose. The weekly drugs are the opposite case. Their long stay is the property that lets them be taken once a week, and it is also why stopping one is a slow event.
How long before pregnancy should it be stopped?
The two labels answer differently, and the difference is worth knowing before a conversation with a doctor.
The Wegovy label gives a time: "discontinue WEGOVY at least 2 months before a planned pregnancy because of the long half-life of semaglutide".2 Two months is eight to nine half-lives, by which point the model shows well under 1% remaining.
The Zepbound label gives no lead time. It says that weight loss "offers no benefit to a pregnant patient and may cause fetal harm", and tells patients "to discontinue ZEPBOUND when a pregnancy is recognized".1 It also notes that the available data in pregnancy are not enough to judge the risk. For someone planning ahead, the calculator shows what the drug level would be on any date after a last dose: under 3% after about four weeks and under 1% after about five. How long to wait is a decision to make with the prescriber, and it is better made before stopping contraception than after.
One more point from the same section of the label: Zepbound can make birth-control pills less reliable for 4 weeks after the first dose and after each dose increase, so the label advises a barrier method or a non-oral contraceptive in those windows. On breastfeeding, the label reports a small study in which the amount of tirzepatide in breast milk was undetectable or low, and says there are no data on effects on the infant.
Does skipping a dose clear it before surgery?
No. The label warns that food and liquid can remain in the stomach during anesthesia in people taking this class of drug, and asks patients "to inform healthcare providers of any planned surgeries or procedures".1 It does not say how long before a procedure to stop.
The model shows why one skipped dose is not the same as being off the drug. Seven days after an injection, when the next dose would be due, 44% of the usual peak is still there. After 14 days, 17%. A person who "skipped this week's shot" arrives with between a sixth and nearly half of their usual level. Whether that matters for a given procedure is for the surgical and anesthesia team to decide. The useful thing to bring them is the date of your last injection and your dose.
What does this mean when switching to another drug?
That the old drug is still there when the new one starts. The Zepbound label says that using it together with another tirzepatide product or with any GLP-1 drug "is not recommended".1 A person who takes the last Wegovy injection on a Monday and a first Zepbound injection the following Monday has about 62% of their usual semaglutide peak on board at that moment, and still about 31% a week later.
Neither label gives a waiting period for a switch between the two brands, so the timing is set by the prescriber. The Zepbound label starts everyone at 2.5 mg, whatever they took before.
What if I start again after it has left?
Then the body meets the drug nearly fresh. The label built the starting schedule around that first meeting: 2.5 mg for 4 weeks, then a rise in steps, "to reduce the risk of gastrointestinal adverse reactions".1 It does not say at what dose to restart after a break, and the answer depends on how long the break was. After one missed week most of the usual level is still there. After four, almost none is.
The date of your last injection and the dose you were on are the two facts a prescriber needs to choose a restart dose. The calculator at the top gives the third: roughly how much of that dose is still with you. Our missed dose page goes through what each label says about late doses and gaps.
Will it show up on a drug test?
The prescribing information says nothing about drug screening. If you are asked to list your medicines before a test or a medical exam, include it along with the dose and the date of the last injection.
Short answers to common questions
How long does 2.5 mg stay in your system?
As long as any other dose in relative terms: about half is gone a week after the peak and about 97% after four weeks. After a single first injection the level is under 3% of a settled peak on about day 23.
How long does 15 mg stay in your system?
The half-life is the same. Because it starts six times higher than 2.5 mg, it takes about two weeks to fall to the level of a 2.5 mg peak and about 40 days to fall to a trace of it.
Is it out of my system when the week is over?
No. A week after an injection about 44% of the peak remains. That overlap is how a weekly dose keeps working until the next one.
Do vials or the KwikPen last longer than the single-dose pen?
No. They hold the same drug in the same doses. The device changes how the dose is measured out and nothing about what happens after it is injected.
Does food or the time of day change it?
No. The dose is injected under the skin, and the label allows it at any time of day, with or without meals.
I skipped one week. Am I starting from zero?
No. Two weeks after an injection about 17% of the usual peak is left, and the next dose brings the level most of the way back. After three or four skipped weeks very little is left, and the label has no rule for the restart dose.
When is a side effect from a dose most likely to show?
The level is highest 8 to 72 hours after the injection, most often at about 24 hours, and falls from then on. The label does not report side effects by day of the week.
Can I donate blood or have lab work while it is in my system?
The label lists no restriction on blood tests and does not mention blood donation. For donation, the blood service decides; tell them the name of the medicine and the date of your last injection.
Does Mounjaro stay as long as Zepbound?
Yes. Both are tirzepatide and the labels give the same pharmacology.
How long after stopping will my appetite come back?
No trial measured it by day. The drug level halves about every week, and in the withdrawal trial weight began to return within the following months.
I took one dose and it did not suit me. How long until it is gone?
The level halves in 5 to 6 days and is down to a few percent of its peak in about three and a half weeks.
How the calculator works
It is a one-compartment model with first-order absorption, the simplest model that reproduces a slow rise and a steady fall. It takes two numbers from each label: the half-life (about 5 days for tirzepatide, about a week for semaglutide) and the time to peak (24 hours and 48 hours). For "weekly doses for a month or more" it assumes a long run of weekly injections before the last one. For "only that one dose" it uses a single injection, shown on the same scale.
The label gives the tirzepatide half-life as 5 to 6 days in one place and about 5 days in another. The model uses 5. With 6, each milestone in the list would fall about a fifth later: day 27 would become roughly day 32. The model describes a typical person, and the label reports about 20% variation in clearance between people. It cannot stand in for a measurement, and it is not a basis for deciding when to stop or restart a medicine.
Sources
- ZEPBOUND (tirzepatide) prescribing information, NDA 217806/S-041, revised August 2026. U.S. Food and Drug Administration; sections 1, 2, 5.9, 7.2, 8.1 to 8.7, 10 and 12. accessdata.fda.gov
- WEGOVY (semaglutide) prescribing information, NDA 215256/S-025, revised June 2026. U.S. Food and Drug Administration; sections 2.4, 8.3 and 12.3. accessdata.fda.gov
- Aronne LJ, Sattar N, Horn DB, et al. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial. JAMA 2024;331:38-48. doi:10.1001/jama.2023.24945
- MOUNJARO (tirzepatide) prescribing information. Eli Lilly and Company; label text as published by the U.S. Food and Drug Administration, July 2026. dailymed.nlm.nih.gov
- Overgaard RV, Agersø H, Hollensen C, Rathor N, Bomberg EM. The impact of missed doses on pharmacokinetic concentrations for oral semaglutide in comparison to other glucagon-like peptide-1-based therapies. Diabetes Obes Metab 2026;28:8735-8739. Funded by Novo Nordisk. doi:10.1111/dom.71030
- Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab 2022;24:1553-1564. doi:10.1111/dom.14725
- Horn DB, Aronne LJ, Wharton S, et al. Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN). Lancet 2026;407:2305-2318. doi:10.1016/S0140-6736(26)00656-2
Related analyses
Switching from Wegovy to Zepbound: the starting dose, the timing, and what the evidence covers
What happens when you stop Zepbound: how much weight comes back, and how fast
Zepbound cost: what you pay with insurance, without it, and over a year
Zepbound maintenance dose: staying on 5, 10 or 15 mg, stepping down, and how long treatment lasts
Log your doses and see the level in your body today.
Open Dose Insider